Mitochondrial disease
Gene: DNAJC19
Multiple reports, disorder characterised by the onset of dilated or noncompaction cardiomyopathy in infancy or early childhood. Many patients die of cardiac failure. Other features include microcytic anemia, growth retardation, mild ataxia, mild muscle weakness, genital anomalies in males, and increased urinary excretion of 3-methylglutaconic acid. Some patients may have optic atrophy or delayed psychomotor developmentCreated: 5 Jan 2022, 11:23 a.m. | Last Modified: 5 Jan 2022, 11:23 a.m.
Panel Version: 0.10477
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
3-methylglutaconic aciduria, type V MIM#610198
Publications
Variants in this GENE are reported as part of current diagnostic practice
Gene: dnajc19 has been classified as Green List (High Evidence).
Phenotypes for gene: DNAJC19 were changed from to 3-methylglutaconic aciduria, type V MIM#610198
Publications for gene: DNAJC19 were set to
Mode of inheritance for gene: DNAJC19 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: DNAJC19 was added gene: DNAJC19 was added to Mitochondrial_AGHA_VCGS. Sources: Expert Review Green,Australian Genomics Health Alliance Mitochondrial Flagship,Victorian Clinical Genetics Services Mode of inheritance for gene: DNAJC19 was set to Unknown